跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Exulten - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Exulten
Approved
STANDARD
Exulten
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
8d05a7c5880599b5
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
8d05a7c5880599b5
Drug Approval Philippines Name
Exulten
Product Name
Exulten
Registration Number
DR-XY34937
Brand Name
Exulten
Generic Name
Sertraline (as hydrochloride)
Dosage Form
Tablet
Dosage Strength
50 mg
Manufacturer
Amherst Laboratories, Inc.
Trader
UNILAB,Inc.
Issuance Date
26 October 2023
Expiry Date
15 September 2028
Pharmacologic Category
Antidepressant
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
8d05a7c5880599b5
Type
Standard
Back to Philippines FDA Approvals